Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064

Expensive Underperformer

Download real time

1050.00 -29.20 (-2.71%)

75.59% Gain from 52W Low

240.0K NSE+BSE Volume

NSE 19 May, 2025 12:31 PM (IST)

26,729.3

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Cohance Lifesciences Ltd. is on 28 May 2025 for the purpose of Audited Results See details

Cohance Lifesciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for COHANCE, BSE:543064 Cohance Lifesciences Ltd.

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

22 Votes:

Buy 63.64%

Sell 13.64%

Hold 22.73%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >